Sujani M. K. Gamage, Chamath D. Ranaweera, Tracie T. Cheng, Sharmin Aktar, Vinod Gopalan & Farhadul Islam. 2023. Current Cancer Biomarkers. Current Cancer Biomarkers
11
32
.
Jiajia Wu, Zedong Li, Kai Zeng, Kangjian Wu, Dong Xu, Jun Zhou & Lijian Xu. (2019) Key genes associated with pancreatic cancer and their association with outcomes: A bioinformatics analysis. Molecular Medicine Reports.
Crossref
Maria Diab & Philip A. Philip. 2018. Current and Emerging Therapies in Pancreatic Cancer. Current and Emerging Therapies in Pancreatic Cancer
119
134
.
Cao Jiakun, Xia Lin & Tang Sheng. (2017) The establishment of detecting carbohydrate antigen 199 (CA199) with immunofluorescence chromatography. The establishment of detecting carbohydrate antigen 199 (CA199) with immunofluorescence chromatography.
Jaihwan Kim. (2017) Assessment of Asymptomatically Increased CA 19-9. Korean Journal of Pancreas and Biliary Tract 22:3, pages 114-117.
Crossref
Brian M. Nolen & Anna E. Lokshin. 2014. Biomarkers in Toxicology. Biomarkers in Toxicology
759
770
.
Hari Kosanam, Ioannis Prassas, Caitlin C. Chrystoja, Ireena Soleas, Alison Chan, Apostolos Dimitromanolakis, Ivan M. Blasutig, Felix Rückert, Robert Gruetzmann, Christian Pilarsky, Masato Maekawa, Randall Brand & Eleftherios P. Diamandis. (2013) Laminin, gamma 2 (LAMC2): A Promising New Putative Pancreatic Cancer Biomarker Identified by Proteomic Analysis of Pancreatic Adenocarcinoma Tissues. Molecular & Cellular Proteomics 12:10, pages 2820-2832.
Crossref
Brian M. Nolen & Anna E. Lokshin. (2018) The Advancement of Biomarker-Based Diagnostic Tools for Ovarian, Breast, and Pancreatic Cancer through the Use of Urine as an Analytical Biofluid. The International Journal of Biological Markers 26:3, pages 141-152.
Crossref
Randall E. Brand, Brian M. Nolen, Herbert J. Zeh, Peter J. Allen, Mohamad A. Eloubeidi, Michael Goldberg, Eric Elton, Juan P. Arnoletti, John D. Christein, Selwyn M. Vickers, Christopher J. Langmead, Douglas P. Landsittel, David C. Whitcomb, William E. Grizzle & Anna E. Lokshin. (2011) Serum Biomarker Panels for the Detection of Pancreatic Cancer. Clinical Cancer Research 17:4, pages 805-816.
Crossref
Felix Rückert, Christian Pilarsky & Robert Grützmann. (2010) Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries. Cancers 2:2, pages 1107-1124.
Crossref
Satyanarayana Rachagani, Maria P. Torres, Nicolas Moniaux & Surinder K. Batra. (2009) Current status of mucins in the diagnosis and therapy of cancer. BioFactors 35:6, pages 509-527.
Crossref
Joris R Delanghe, Marc L De Buyzere, Veerle Casneuf & Marc Peeters. (2008) Unusual Serum Electrophoresis Pattern in a Woman with Pancreatic Carcinoma. Clinical Chemistry 54:9, pages 1572-1574.
Crossref
Sam Pappas, Michael P. Federle, Anna E. Lokshin & Herbert J. ZehIIIIII. (2007) Early Detection and Staging of Adenocarcinoma of the Pancreas. Gastroenterology Clinics of North America 36:2, pages 413-429.
Crossref
Gunnar Folprecht, Michael Geißler, Diana Lüftner, Helmut Öttle, Kurt Possinger & Anne C. Regierer. 2007. Facharzt Hämatologie Onkologie. Facharzt Hämatologie Onkologie
573
690
.
H. Oettle, A. Goerke, A. Kaiser, V. Budach & P. Vogel. 2007. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
713
733
.
Thomas Seufferlein & Guido Adler. 2004. Clinical Pancreatology. Clinical Pancreatology
377
382
.